Advertisement

Recurrent Miscarriage

Chapter

Abstract

Recurrent miscarriage is a common pathology fond in 1% to 5% of reproductively active couples. This chapter discusses the possible causes of recurrent miscarriage, and delineates a cost effective, productive strategy for the clinical evaluation of couples with two or more miscarriages.

Keywords

Recurrent miscarriage Abortion Uterine anomalies Aneuploidy Antiphospholipid antibodies Alloimmunity Thrombophilia 

References

  1. 1.
    Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368(9535):601-611PubMedCrossRefGoogle Scholar
  2. 2.
    Hustin J, Schaaps JP (1987) Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am J Obstet Gynecol 157(1):162-168PubMedGoogle Scholar
  3. 3.
    Jauniaux E, Hempstock J, Greenwold N, Burton GJ (2003) Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 162(1):115-125PubMedGoogle Scholar
  4. 4.
    Burton GJ, Watson AL, Hempstock J, Skepper JN, Jauniaux E (2002) Uterine glands provide histiotrophic nutrition for the uman fetus during the first trimester of pregnancy. J Clin Endocrinol Metab 87:2954-2959PubMedCrossRefGoogle Scholar
  5. 5.
    Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ (2000) Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 157(6):2111-2122PubMedGoogle Scholar
  6. 6.
    Copp AJ (1995) Death before birth: clues from gene knockouts and mutations. Trends Genet 11(3):87-93PubMedCrossRefGoogle Scholar
  7. 7.
    Shepard TH, Fantel AG, Fitzsimmons J (1989) Congenital defect rates among spontaneous abortuses: twenty years of monitoring. Teratology 39(4):325-331PubMedCrossRefGoogle Scholar
  8. 8.
    Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M (2000) Maternal age and fetal loss: population based register linkage study. BMJ 320(7251):1708-1712PubMedCrossRefGoogle Scholar
  9. 9.
    Stein Z, Kline J, Susser E (1980) Maternal age and spontaneous abortion. In: Porter I, Hook E (eds) Human embryonic and fetal death. Academic, New YorkGoogle Scholar
  10. 10.
    Harlap S, Shiono P, Ramcharan S (1980) A life table of spontaneous abortions and the effects of age, parity, and other variables. In: Porter I, Hook E (eds) Human embronic and fetal death. Academic, New York, p 145Google Scholar
  11. 11.
    Christiansen OB, Steffensen R, Nielsen HS, Varming K (2008) Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol Obstet Invest 66(4):257-267PubMedCrossRefGoogle Scholar
  12. 12.
    Kleinhaus K, Perrin M, Friedlander Y, Paltiel O, Malaspina D, Harlap S (2006) Paternal age and spontaneous abortion. Obstet Gynecol 108(2):369-377PubMedGoogle Scholar
  13. 12a.
    Mishra GD, Dobson AJ, Schofield MJ (2000) Cigarette smoking, menstrual symptoms and miscarriage among young women. Aust N Z J Public Health 24(4):413-420PubMedCrossRefGoogle Scholar
  14. 13.
    Henriksen TB, Hjollund NH, Jensen TK et al (2004) Alcohol consumption at the time of conception and spontaneous abortion. Am J Epidemiol 160(7):661-667PubMedCrossRefGoogle Scholar
  15. 14.
    Weng X, Odouli R (2008) Li DK (2008) Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 198(3):279 e1-8PubMedGoogle Scholar
  16. 15.
    Maconochie N, Doyle P, Prior S, Simmons R (2007) Risk factors for first trimester miscarriage - results from a UK-population-based case-control study. BJOG 114:170-186PubMedCrossRefGoogle Scholar
  17. 16.
    Henderson J, Gray R, Brocklehurst P (2007) Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG 114(3):243-252PubMedCrossRefGoogle Scholar
  18. 17.
    George L, Granath F, Johansson AL, Olander B, Cnattingius S (2006) Risks of repeated miscarriage. Paediatr Perinat Epidemiol 20(2):119-126PubMedCrossRefGoogle Scholar
  19. 18.
    Hemels ME, Einarson A, Koren G, Lanctot KL, Einarson TR (2005) Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 39(5):803-809PubMedCrossRefGoogle Scholar
  20. 19.
    The ESHRE Capri Workshop Group (2006) Nutrition and reproduction in women. Hum Reprod Update 12(3):193-207Google Scholar
  21. 20.
    Stephenson MD, Awartani KA, Robinson WP (2002) Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod 17(2):446-451PubMedCrossRefGoogle Scholar
  22. 21.
    Stern JJ, Dorfmann AD, Gutierrez-Najar AJ, Cerrillo M, Coulam CB (1996) Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 65(2):250-253PubMedGoogle Scholar
  23. 22.
    Vidal F, Gimenez C, Rubio C et al (1998) FISH preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy wastage. J Assist Reprod Genet 15(5):310-313PubMedCrossRefGoogle Scholar
  24. 23.
    Simon C, Rubio C, Vidal F et al (1998) Increased chromosome abnormalities in human preimplantation embryos after in-vitro fertilization in patients with recurrent miscarriage. Reprod Fertil Dev 10(1):87-92PubMedCrossRefGoogle Scholar
  25. 24.
    Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW (2004) Recurrent fetal aneuploidy and recurrent miscarriage. Obstet Gynecol 104(4):784-788PubMedGoogle Scholar
  26. 25.
    Ogasawara M, Aoki K, Okada S, Suzumori K (2000) Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 73(2):300-304PubMedCrossRefGoogle Scholar
  27. 26.
    Carp H, Toder V, Aviram A, Daniely M, Mashiach S, Barkai G (2001) Karyotype of the abortus in recurrent miscarriage. Fertil Steril 75(4):678-682PubMedCrossRefGoogle Scholar
  28. 27.
    De Braekeleer M, Dao TN (1990) Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum Reprod 5(5):519-528PubMedGoogle Scholar
  29. 28.
    Clifford K, Rai R, Watson H, Regan L (1994) An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 9(7):1328-1332PubMedGoogle Scholar
  30. 29.
    Carp H, Feldman B, Oelsner G, Schiff E (2004) Parental karyotype and subsequent live births in recurrent miscarriage. Fertil Steril 81(5):1296-1301PubMedCrossRefGoogle Scholar
  31. 30.
    Gynecologists ACoOa (2001) Management of recurrent early pregnancy loss. ACOG Practice Bulletin No 24Google Scholar
  32. 31.
    Gynaecologists RCoOa (2003) The investigation and treatment of women with recurrent miscarriage. TCOG Guideline No 17Google Scholar
  33. 32.
    Pegoraro E, Whitaker J, Mowery-Rushton P, Surti U, Lanasa M, Hoffman EP (1997) Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28. Am J Hum Genet 61(1):160-170PubMedCrossRefGoogle Scholar
  34. 33.
    Lanasa MC, Hogge WA, Kubik C, Blancato J, Hoffman EP (1999) Highly skewed X-chromosome inactivation is associated with idiopathic recurrent spontaneous abortion. Am J Hum Genet 65(1):252-254PubMedCrossRefGoogle Scholar
  35. 34.
    Sullivan AE, Lewis T, Stephenson M et al (2003) Pregnancy outcome in recurrent miscarriage patients with skewed X chromosome inactivation. Obstet Gynecol 101(6):1236-1242PubMedCrossRefGoogle Scholar
  36. 35.
    Hogge WA, Prosen TL, Lanasa MC, Huber HA, Reeves MF (2007) Recurrent spontaneous abortion and skewed X-inactivation: is there an association? Am J Obstet Gynecol 196(4):384 e1-6; discussion e6-8PubMedCrossRefGoogle Scholar
  37. 36.
    Kaare M, Painter J, Ulander V-M, Kaaja R, Aittomoaki K (2008) Sex chromosome characteristics and recurrent miscarriage. Fertil Steril 90:2328-2333PubMedCrossRefGoogle Scholar
  38. 37.
    Salim R, Regan L, Woelfer B, Backos M, Jurkovic D (2003) A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod 18(1):162-166PubMedCrossRefGoogle Scholar
  39. 38.
    Woelfer B, Salim R, Banerjee S, Elson J, Regan L, Jurkovic D (2001) Reproductive outcomes in women with congenital uterine anomalies detected by three-dimensional ultrasound screening. Obstet Gynecol 98(6):1099-1103PubMedCrossRefGoogle Scholar
  40. 39.
    Du H, Taylor HS (2004) Molecular regulation of mullerian development by Hox genes. Ann N Y Acad Sci 1034:152-165PubMedCrossRefGoogle Scholar
  41. 40.
    Wong KH, Wintch HD, Capecchi MR (2004) Hoxa11 regulates stromal cell death and proliferation during neonatal uterine development. Mol Endocrinol 18(1):184-193PubMedCrossRefGoogle Scholar
  42. 41.
    Kupesic S, Kurjak A (1998) Septate uterus: detection and prediction of obstetrical complications by different forms of ultrasonography. J Ultrasound Med 17(10):631-636PubMedGoogle Scholar
  43. 42.
    Heinonen PK (1997) Reproductive performance of women with uterine anomalies after abdominal or hysteroscopic metroplasty or no surgical treatment. J Am Assoc Gynecol Laparosc 4(3):311-317PubMedCrossRefGoogle Scholar
  44. 43.
    Valli E, Vaquero E, Lazzarin N, Caserta D, Marconi D, Zupi E (2004) Hysteroscopic metroplasty improves gestational outcome in women with recurrent spontaneous abortion. J Am Assoc Gynecol Laparosc 11(2):240-244PubMedCrossRefGoogle Scholar
  45. 44.
    Stovall DW, Parrish SB, Van Voorhis BJ, Hahn SJ, Sparks AE, Syrop CH (1998) Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod 13(1):192-197PubMedCrossRefGoogle Scholar
  46. 45.
    Hart R, Khalaf Y, Yeong CT, Seed P, Taylor A, Braude P (2001) A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod 16(11):2411-2417PubMedGoogle Scholar
  47. 46.
    Klatsky PC, Tran ND, Caughey AB, Fujimoto VY (2008) Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol 198(4):357-366PubMedCrossRefGoogle Scholar
  48. 47.
    Duggan MA, Brashert P, Ostor A et al (2001) The accuracy and interobserver reproducibility of endometrial dating. Pathology 33(3):292-297PubMedCrossRefGoogle Scholar
  49. 48.
    Ogasawara M, Kajiura S, Katano K, Aoyama T, Aoki K (1997) Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies? Fertil Steril 68(5):806-809PubMedCrossRefGoogle Scholar
  50. 49.
    Usadi RS, Groll JM, Lessey BA et al (2008) Endometrial development and function in experimentally induced luteal phase deficiency. J Clin Endocrinol Metab 93(10):4058-4064PubMedCrossRefGoogle Scholar
  51. 50.
    Karamardian L, Grimes D (1994) Luteal phase deficiency: effect of treatment on pregnancy rates. Am J Obstet Gynecol 170:958-959Google Scholar
  52. 51.
    Walch K, Hefler L, Nagele F (2005) Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial. J Matern Fetal Neonatal Med 18(4):265-269PubMedCrossRefGoogle Scholar
  53. 52.
    Harrison RF (1992) Human chorionic gonadotrophin (hCG) in the management of recurrent abortion; results of a multi-centre placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 47(3):175-179PubMedCrossRefGoogle Scholar
  54. 53.
    Clifford K, Rai R, Watson H, Franks S, Regan L (1996) Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ 312(7045):1508-1511PubMedGoogle Scholar
  55. 54.
    Craig LB, Ke RW, Kutteh WH (2002) Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 78(3):487-490PubMedCrossRefGoogle Scholar
  56. 55.
    Zolghadri J, Tavana Z, Kazerooni T, Soveid M, Taghieh M (2008) Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: a prospective clinical study. Fertil Steril 90(3):727-730PubMedCrossRefGoogle Scholar
  57. 56.
    Rowan JA, Hague WM, Gao W, Battin MR, Moore MP (2008) Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358(19):2003-2015PubMedCrossRefGoogle Scholar
  58. 57.
    Mills JL, Simpson JL, Driscoll SG et al (1988) Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 319(25):1617-1623PubMedCrossRefGoogle Scholar
  59. 58.
    Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O (2002) Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12(1):63-68PubMedCrossRefGoogle Scholar
  60. 59.
    Christiansen OB, Nybo Andersen AM, Bosch E et al (2005) Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 83(4):821-839PubMedCrossRefGoogle Scholar
  61. 60.
    Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295-306PubMedCrossRefGoogle Scholar
  62. 61.
    Rai R, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314(7076):253-257PubMedGoogle Scholar
  63. 62.
    Kutteh WH (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174(5):1584-1589PubMedCrossRefGoogle Scholar
  64. 63.
    Farquharson RG, Quenby S, Greaves M (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100(3):408-413PubMedCrossRefGoogle Scholar
  65. 64.
    Branch DW, Khamashta MA (2003) Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 101(6):1333-1344PubMedCrossRefGoogle Scholar
  66. 65.
    Holers VM, Girardi G, Mo L et al (2002) Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195(2):211-220PubMedCrossRefGoogle Scholar
  67. 66.
    Salmon JE, Girardi G, Theodore E (2007) Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation. Trans Am Clin Climatol Assoc 118:99-114PubMedGoogle Scholar
  68. 67.
    Oku K, Atsumi T, Bohgaki M et al (2009) Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis 68:1030-1035PubMedCrossRefGoogle Scholar
  69. 68.
    Branch DW, Peaceman AM, Druzin M et al (2000) A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182(1 Pt 1):122-127PubMedCrossRefGoogle Scholar
  70. 69.
    Triolo G, Ferrante A, Ciccia F et al (2003) Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48(3):728-731PubMedCrossRefGoogle Scholar
  71. 70.
    Wisloff F, Crowther M (2004) Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure. Thromb Res 114(2):75-81PubMedCrossRefGoogle Scholar
  72. 71.
    Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF (1990) Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264(11):1422-1425PubMedCrossRefGoogle Scholar
  73. 72.
    Esplin MS, Branch DW, Silver R, Stagnaro-Green A (1998) Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol 179(6 Pt 1):1583-1586PubMedCrossRefGoogle Scholar
  74. 73.
    Rushworth FH, Backos M, Rai R, Chilcott IT, Baxter N, Regan L (2000) Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod 15(7):1637-1639PubMedCrossRefGoogle Scholar
  75. 74.
    Abramson J, Stagnaro-Green A (2001) Thyroid antibodies and fetal loss: an evolving story. Thyroid 11(1):57-63PubMedCrossRefGoogle Scholar
  76. 75.
    Ogasawara M, Aoki K, Katano K, Aoyama T, Kajiura S, Suzumori K (1999) Prevalence of autoantibodies in patients with recurrent miscarriages. Am J Reprod Immunol 41(1):86-90PubMedGoogle Scholar
  77. 76.
    Laskin CA, Bombardier C, Hannah ME et al (1997) Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 337(3):148-153PubMedCrossRefGoogle Scholar
  78. 77.
    Lockwood CJ (2002) Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 99(2):333-341PubMedCrossRefGoogle Scholar
  79. 78.
    Brenner B, Mandel H, Lanir N et al (1997) Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 97(3):551-554PubMedCrossRefGoogle Scholar
  80. 79.
    Ridker PM, Miletich JP, Buring JE et al (1998) Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 128(12 Pt 1):1000-1003PubMedGoogle Scholar
  81. 80.
    Foka ZJ, Lambropoulos AF, Saravelos H et al (2000) Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 15(2):458-462PubMedCrossRefGoogle Scholar
  82. 81.
    Kutteh WH, Park VM, Deitcher SR (1999) Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 71(6):1048-1053PubMedCrossRefGoogle Scholar
  83. 82.
    Pauer HU, Neesen J, Hinney B (1998) Factor V Leiden and its relevance in patients with recurrent abortions. Am J Obstet Gynecol 178(3):629PubMedGoogle Scholar
  84. 83.
    Rodger MA, Paidas M, Claire M et al (2008) Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 112(2 Pt 1):320-324PubMedGoogle Scholar
  85. 84.
    Roque H, Paidas MJ, Funai EF, Kuczynski E, Lockwood CJ (2004) Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 91(2):290-295PubMedGoogle Scholar
  86. 85.
    Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B (2002) Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 77(2):342-347PubMedCrossRefGoogle Scholar
  87. 86.
    Rai R, Shlebak A, Cohen H et al (2001) Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 16(5):961-965PubMedCrossRefGoogle Scholar
  88. 87.
    Dawood F, Mountford R, Farquharson R, Quenby S (2007) Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR. Hum Reprod 22(9):2546-2553PubMedCrossRefGoogle Scholar
  89. 88.
    Rai R, Regan L, Hadley E, Dave M, Cohen H (1996) Second-trimester pregnancy loss is associated with activated C resistance. Br J Haematol 92(2):489-490PubMedGoogle Scholar
  90. 89.
    Gris JC, Quere I, Monpeyroux F et al (1999) Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent - the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost 81(6):891-899PubMedGoogle Scholar
  91. 90.
    Martinelli I, Taioli E, Cetin I et al (2000) Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 343(14):1015-1018PubMedCrossRefGoogle Scholar
  92. 91.
    SCRN. Research on the scope and causes of stillbirth in the United StatesGoogle Scholar
  93. 92.
    Gris JC, Mercier E, Quere I et al (2004) Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 103(10):3695-3699PubMedCrossRefGoogle Scholar
  94. 93.
    Christiansen OB, Rasmussen KL, Jersild C, Grunnet N (1994) HLA class II alleles confer susceptibility to recurrent fetal losses in Danish women. Tissue Antigens 44(4):225-233PubMedCrossRefGoogle Scholar
  95. 94.
    Christiansen OB, Mathiesen O, Husth M, Lauritsen JG, Jersild C, Grunnet N (1993) Prognostic significance of maternal DR histocompatibility types in Danish women with recurrent miscarriages. Hum Reprod 8(11):1843-1847PubMedGoogle Scholar
  96. 95.
    Christiansen OB, Andersen HH, Hojbjerre M, Kruse TA, Lauritzen SL, Grunnet N (1995) Maternal HLA class II allogenotypes are markers for the predisposition to fetal losses in families of women with unexplained recurrent fetal loss. Eur J Immunogenet 22(4):323-334PubMedCrossRefGoogle Scholar
  97. 96.
    Hviid TV, Christiansen OB (2005) Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G-possible implications for human reproduction and autoimmune disease. Hum Immunol 66(6):688-699PubMedCrossRefGoogle Scholar
  98. 97.
    Ober C (1999) Studies of HLA, fertility and mate choice in a human isolate. Hum Reprod Update 5(2):103-107PubMedCrossRefGoogle Scholar
  99. 98.
    Aldrich CL, Stephenson MD, Karrison T et al (2001) HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 7(12):1167-1172PubMedCrossRefGoogle Scholar
  100. 99.
    Pfeiffer KA, Fimmers R, Engels G, van der Ven H, van der Ven K (2001) The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 7(4):373-378PubMedCrossRefGoogle Scholar
  101. 100.
    Ober C, Aldrich CL, Chervoneva I et al (2003) Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 72(6):1425-1435PubMedCrossRefGoogle Scholar
  102. 101.
    Patel RN, Quack KC, Hill JA, Schust DJ (2003) Expression of membrane-bound HLA-G at the maternal-fetal interface is not associated with pregnancy maintenance among patients with idiopathic recurrent pregnancy loss. Mol Hum Reprod 9(9):551-557PubMedCrossRefGoogle Scholar
  103. 102.
    Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB (2002) HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 60(2):122-132PubMedCrossRefGoogle Scholar
  104. 103.
    Tripathi P, Abbas A, Naik S, Agrawal S (2004) Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 64(6):706-710PubMedCrossRefGoogle Scholar
  105. 104.
    Xue S, Yang J, Yao F, Xu L, Fan L (2007) Recurrent spontaneous abortions patients have more -14 bp/+14 bp heterozygotes in the 3'UT region of the HLA-G gene in a Chinese Han population. Tissue Antigens 69(Suppl. 1):153-155PubMedCrossRefGoogle Scholar
  106. 105.
    Aoki K, Kajiura S, Matsumoto Y et al (1995) Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 345(8961):1340-1342PubMedCrossRefGoogle Scholar
  107. 106.
    Beer AE, Kwak JY, Ruiz JE (1996) Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol 35(4):376-382PubMedGoogle Scholar
  108. 107.
    Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H (2003) Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 50(4):351-354PubMedCrossRefGoogle Scholar
  109. 108.
    Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I (2000) Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 15(5):1163-1169PubMedCrossRefGoogle Scholar
  110. 109.
    Dosiou C, Giudice LC (2005) Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 26(1):44-62PubMedCrossRefGoogle Scholar
  111. 110.
    Lachapelle MH, Miron P, Hemmings R, Roy DC (1996) Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 156(10):4027-4034PubMedGoogle Scholar
  112. 111.
    Quenby S, Bates M, Doig T et al (1999) Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 14(9):2386-2391PubMedCrossRefGoogle Scholar
  113. 112.
    Clifford K, Flanagan AM, Regan L (1999) Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 14(11):2727-2730PubMedCrossRefGoogle Scholar
  114. 113.
    Tuckerman E, Laird S, Prakash A, Li T (2008) Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod 22:2208-2213CrossRefGoogle Scholar
  115. 114.
    Michimata T, Ogasawara MS, Tsuda H et al (2002) Distributions of endometrial NK cells, B cells, T cells, and Th2/Tc2 cells fail to predict pregnancy outcome following recurrent abortion. Am J Reprod Immunol 47(4):196-202PubMedCrossRefGoogle Scholar
  116. 115.
    Shimada S, Kato EH, Morikawa M et al (2004) No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 19(4):1018-1024PubMedCrossRefGoogle Scholar
  117. 116.
    Quenby S, Kalumbi C, Bates M, Farquharson R, Vince G (2005) Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril 84(4):980-984PubMedCrossRefGoogle Scholar
  118. 117.
    Porter TF, LaCoursiere Y, Scott JR (2006) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev (2):CD000112Google Scholar
  119. 118.
    Ober C, Karrison T, Odem RR et al (1999) Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 354(9176):365-369PubMedCrossRefGoogle Scholar
  120. 119.
    Frias AE Jr, Luikenaar RA, Sullivan AE et al (2004) Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 104(3):521-526PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, Division of Maternal Fetal MedicineUniversity of Utah School of MedicineSalt Lake CityUSA

Personalised recommendations